SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-000834
Filing Date
2024-02-29
Accepted
2024-02-29 21:01:05
Documents
1
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3956
  Complete submission text file 0000905148-24-000834.txt   5673
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Garren Hideki (Reporting) CIK: 0001854126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 24706540